COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 2547: Articles 25461-25470  | Next

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia
Temesgen, Z., Assi, M., Vergidis, P., Rizza, S. A., Bauer, P. R., Pickering, B. W., Razonable, R. R., Libertin, C. R., Burger, C. D., Orenstein, R., Vargas, H. E., Varatharaj Palraj, B. R., Dababneh, A. S., Chappell, G., Chappell, D., Ahmed, O., Sakemura, R., Durrant, C., Kenderian, S. S., Bradley, A.
10.1101/2020.06.08.20125369 — Posted: 2020-06-12
Persistent SARS-CoV-2 replication in severe COVID-19
Folgueira, M. D., Luczkowiak, J., Lasala, F., Perez-Rivilla, A., Delgado, R.
10.1101/2020.06.10.20127837 — Posted: 2020-06-12 Discussion: Onsite | Offsite
The origin and early spread of SARS-CoV-2 in Europe
Nadeau, S. A., Vaughan, T. G., Scire, J., Huisman, J. S., Stadler, T.
10.1101/2020.06.10.20127738 — Posted: 2020-06-12
Even one metre seems generous. A reanalysis of data in: Chu et al. (2020) Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19.
Lonergan, M.
10.1101/2020.06.11.20127415 — Posted: 2020-06-12
Evaluation of 30-day mortality for 500 patients undergoing non-emergency surgery in a COVID-19 cold site within a multicentre regional surgical network during the COVID-19 pandemic
Kasivisvanathan, V., Lindsay, J., Rakhshani-moghadam, S., Elhamshary, A., Kapriniotis, K., Kazantzis, G., Syed, B., Hines, J., Bex, A., Heffernan Ho, D., Hayward, M., Bhan, C., MacDonald, N., Clarke, S., Walker, D., Bellingan, G., Moore, J., Rohn, J., Muneer, A., Roberts, L., Haddad, F., Kelly, J. D.
10.1101/2020.06.10.20115543 — Posted: 2020-06-12
Tracking and Classifying Global COVID-19 Cases by using 1D Deep Convolution Neural Network
Amo-Boateng, M.
10.1101/2020.06.09.20126565 — Posted: 2020-06-12
Lack of sufficient public space can limit the effectiveness of COVID-19's social distancing measures
Nobajas, A., Ganau i Casas, J., Paul i Agusti, D., Peacock, A. J.
10.1101/2020.06.07.20124982 — Posted: 2020-06-12
Serology-informed estimates of SARS-COV-2 infection fatality risk in Geneva, Switzerland
Perez-Saez, J., Lauer, S. A., Kaiser, L., Regard, S., Delaporte, E., Guessous, I., Stringhini, S., Azman, A. S., Serocov-POP Study Group
10.1101/2020.06.10.20127423 — Posted: 2020-06-12 Discussion: Offsite
Identifying novel factors associated with COVID-19 transmission and fatality using the machine learning approach
Li, M., Zhang, Z., Cao, W., Liu, Y., Du, B., Chen, C., Liu, Q., Uddin, M. N., Jiang, S., Chen, C., Zhang, Y., Wang, X.
10.1101/2020.06.10.20127472 — Posted: 2020-06-12
Correlation between meteorological factors and COVID-19 infection in the Belem Metropolitan Region
da Silva, F. L., A. Gomes, M. D., Lelis da Silva, A. P., de Sousa, S. C., Serafim de Souza, M. F., P. da Silva, G. L.
10.1101/2020.06.10.20127506 — Posted: 2020-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).